News | MRI Breast | September 15, 2015

BEST Act ensures quality screening and treatment options throughout state

Komen, Rep. Smiddy, BEST Act, breast cancer law, screening, MRI, Illinois

September 15, 2015 — The Susan G. Komen Illinois Affiliates applaud Rep. Mike Smiddy (D-Hillsdale) on the passage of the Breast Cancer Excellence in Survival and Treatment Act (BEST Act, HB3673) into law.

The new legislation acts as an amendment to the Illinois Insurance Code and the Illinois Public Aid Code as it relates to coverage and payment for screening by low-dose mammography for all women 35 years of age or older for the presence of occult breast cancer.

Key components of the new legislation include:

  • Requirement for all Medicaid health plans to include American College of Radiology Breast Centers of Imaging Excellence and Academic or Comprehensive Commission on Cancer Accredited centers in their networks, so that women can access the highest quality care;
  • Establishment of a breast cancer treatment quality program and expanded help to women diagnosed with breast cancer who are navigating the healthcare system; and
  • Ensuring medically necessary magnetic resonance imaging (MRI) screening as recommended by a licensed physician will be covered by insurance in Illinois.

The final version of the legislation passed both houses on May 31, and Illinois Gov. Bruce Rauner signed the bill into law on August 21.  

Sean Tenner, Komen Chicago's board president, began working with Rep. Smiddy over 18 months ago when Smiddy's wife, Deb, was fighting breast cancer.

"We applaud Representative Smiddy on his efforts to ensure Illinois women have access to necessary breast health services, and making breast cancer a top priority this past legislative session," Tenner noted.

For more information: www.ilga.gov/legislation


Related Content

News | Breast Biopsy Systems

Feb. 18, 2026 — Mammotome, a Danaher company, has introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy ...

Time February 18, 2026
arrow
News | Breast Imaging

Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...

Time February 17, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 06, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
News | FDA

Feb. 2, 2026 — Imagion Biosystems, Ltd. has submitted an Investigational New Drug (IND) application with the U.S. Food ...

Time February 02, 2026
arrow
News | Breast Imaging | Washington University

Jan. 22, 2026 — In breast cancer, a biopsy is the only diagnostic procedure that can determine if a suspicious lump or ...

Time January 29, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
News | Breast Imaging

Jan. 027, 2026 — QT Imaging and Olea Medical have announced plans to collaborate. This collaboration enhances QT Imaging ...

Time January 27, 2026
arrow
Subscribe Now